^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Lipoplatin (cisplatin liposomal)

    Associations

    News

    Trials
    Company:
    Regulon
    Drug class:
    DNA cross linking agent
    Related drugs:
    Associations

    News

    Trials
    2years
    Comparison of Cytotoxic and Ototoxic Effects of Lipoplatin and Cisplatin in Neuroblastoma In Vivo Tumor Model. (PubMed, J Int Adv Otol)
    For the treatment of neuroblastoma, the use of lipoplatin seems to be beneficial in reducing side effects of cisplatin. We recommend that the mechanism of these properties of lipoplatin should be evaluated in further studies.
    Preclinical • Journal
    |
    NOS2 (Nitric Oxide Synthase 2) • SOD2 (Superoxide Dismutase 2)
    |
    PTGS2 mutation
    |
    Lipoplatin (cisplatin liposomal)